ArticleJournal of immunology (Baltimore, Md. : 1950)2026
The subset of M1-paired MHC class II conformers is critical for CD4+ T cell activation.
Article in Journal of immunology (Baltimore, Md. : 1950), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Phylogenetic analysis of amino acid sequences indicates a central role of transmembrane domain structural elements in MHC class II function.Journal of immunology (Baltimore, Md. : 1950) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Major histocompatibility complex class II molecules present exogenous antigen-derived peptide to CD4+ T cells leading to T cell activation as well as signaling into the antigen-presenting cell. Class II is an αβ heterodimer that forms 2 distinct conformers via differential pairing of transmembrane domain GxxxG motifs (i.e. M1- and M2-paired class II). Previous studies with mouse I-Ak and human HLA-DR class II used conformer-specific monoclonal antibodies (mAbs) to define unique immunobiological properties of each conformer. Here, we report that AMS-32.1, a widely used anti-I-Ad mAb, is-specific for the 20% of M1-paired I-Ad class II expressed by the cell, and 34-5-3S anti-I-Ad mAb is non-conformer specific. While AMS-32.1 engagement of M1-paired I-Ad elicits B cell calcium signaling, 34-5-3S coengagement of M1 and M2-paired I-Ad blocks this response, indicating M2-paired class II inhibits M1-paired class II signaling. In vitro, AMS-32.1 blocks >90% of T cell activation by ovalbumin peptide-I-Ad complexes, even under conditions where peptide is loaded onto both conformers. In vivo, AMS-32.1 blocks accumulation of ovalbumin-specific CD4+ T cells in the spleen and lymph nodes. In a murine model of hepatitis B virus replication, in which major histocompatibility complex class II-restricted T cell-dependent humoral responses are key to antigen clearance, AMS-32.1 blocks hepatitis B surface antigen seroconversion, indicating that M1-paired class II is central to the in vivo development of CD4+ T cell-dependent antibody responses. Overall, this study reveals that AMS-32.1 is specific for M1-paired I-Ad class II and that M1-paired class II is critical for CD4+ T cell activation both in vitro and in vivo.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.